France Telecom, LVL Medical, Vetoquinol: Europe Equity Preview

Shares of the following companies may have unusual moves in European trading. Stock symbols are in parentheses.

The Stoxx Europe 600 Index declined 0.1 percent to 271.87. The Stoxx 50 Index fell 0.1 percent to 2,537.51. The Euro Stoxx 50 Index, a benchmark for nations using the euro, rose 0.3 percent to 2,774.5.

Eurogerm (ALGEM) SA: The maker of food ingredients said it formed a joint venture with Nisshin Seifun in China. The shares were unchanged at 14.61 euros.

France Telecom SA (FTE) : Chief Executive Officer Stephane Richard defended the company’s dividend after criticism from trade unions. The 1.40 euro ($2.05) a share payout, which represented about 45 percent of 2010 free cash flow, “is on the same basis as that of all the major listed telecom operators,” he said. The shares gained 0.1 percent to 15.30 euros.

LVL Medical Groupe SA (LVL) : Malakoff Mederic owns 10.29 percent of the home health-care company, Autorite des Marches Financieres said. The shares climbed 1.9 percent to 17.94 euros.

Manitou Group (MTU FP): The industrial-vehicle maker said Serge Bosche, vice president of sales and marketing for the Americas region, resigned effective June 30. Daniel Miller, president of the Compact division, will take over his duties until a replacement can be found, the company said. The shares fell 0.2 percent to 20.85 euros.

Meetic (MEET) SA: FMR LLC cut its voting right stake in the operator of Europe’s largest online dating network to 4.58 percent, Autorite des Marches Financieres said. The shares rose 0.1 percent to 14.97 euros.

Vetoquinol SA (VETO) : The diagnostic tests maker said it bought Farmagricola SA in Brazil. The shares declined 0.2 percent to 30.15 euros.

To contact the reporter on this story: Inyoung Hwang in New York at

To contact the editor responsible for this story: Nick Baker at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.